The Assistance Fund Opens New Program for Atopic Dermatitis

AccessWire - 01 Apr 2024
ORLANDO, FL / ACCESSWIRE / April 1, 2024 / The Assistance Fund, an independent charitable patient assistance organization that helps patients and families ...

Tapinarof Cream for Adult, Pediatric Eczema Under FDA Review

Medscape - 30 Apr 2024
Tapinarof Cream for Adult, Pediatric Eczema Under FDA Review ...

Antibiotics in Infancy Tied to Higher Risk for Atopic Dermatitis

Medpage Today - 29 Apr 2024
Antibiotics in Infancy Tied to Higher Risk for Atopic Dermatitis ...

Study investigates the potential effects of neonatal vitamin D on eczema up to adulthood

News-Medical.Net - 30 Apr 2024
Study investigates the potential effects of neonatal vitamin D on eczema up to adulthood ...

Spatial modeling connecting childhood atopic dermatitis prevalence with household exposure to pollutants ...

Nature.com - 18 Apr 2024
Spatial modeling connecting childhood atopic dermatitis prevalence with household exposure to pollutants ... ...

FDA Accepts Tapinarof Cream sNDA for Atopic Dermatitis Patients Aged 2 Years and Older

MD Magazine - 29 Apr 2024
FDA Accepts Tapinarof Cream sNDA for Atopic Dermatitis Patients Aged 2 Years and Older ...

Eczema and Stress: Triggers, Connection, and More

Healthline - 25 Apr 2024
Eczema and Stress: Triggers, Connection, and More ...

Scrotal eczema: Symptoms, causes, and treatment

Medical News Today - 12 Mar 2024
Scrotal eczema: Symptoms, causes, and treatment ...

New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary ...

PR Newswire - 25 Apr 2024
New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary ... ...

Technoderma begins dosing in atopic dermatitis therapy trial

Clinical Trials Arena - 30 Apr 2024
Technoderma begins dosing in atopic dermatitis therapy trial ...

Eli Lilly Resubmits BLA for Lebrikizumab for the Treatment of Moderate to Severe AD

Dermatology Times - 30 Apr 2024
Eli Lilly Resubmits BLA for Lebrikizumab for the Treatment of Moderate to Severe AD ...

Ruxolitinib Achieves Disease Control in Mild to Moderate Atopic Dermatitis

Dermatology Advisor - 26 Apr 2024
Ruxolitinib Achieves Disease Control in Mild to Moderate Atopic Dermatitis ...

FDA Accepts Supplemental New Drug Application for Tapinarof Cream, 1%, in Atopic Dermatitis

Pharmacy Times - 29 Apr 2024
FDA Accepts Supplemental New Drug Application for Tapinarof Cream, 1%, in Atopic Dermatitis ...

The Best Soap for Eczema (Atopic Dermatitis)? Try a Nonsoap Cleanser Instead

Everyday Health - 03 Apr 2024
The Best Soap for Eczema (Atopic Dermatitis)? Try a Nonsoap Cleanser Instead ...

FDA accepts supplemental NDA for Vtama cream for atopic dermatitis in adults, children

Healio - 29 Apr 2024
FDA accepts supplemental NDA for Vtama cream for atopic dermatitis in adults, children ...

Upadacitinib Superior in Efficacy to Dupilumab for Atopic Dermatitis in Head-to-Head Study

MD Magazine - 25 Apr 2024
Upadacitinib Superior in Efficacy to Dupilumab for Atopic Dermatitis in Head-to-Head Study ...

Topical Treatment for Atopic Dermatitis

Medscape - 16 Nov 2023
Topical Treatment for Atopic Dermatitis ...

Population-based cohort study to investigate the changes in prevalence, severity profile, and treatment modalities used ...

Nature.com - 05 Apr 2024
Population-based cohort study to investigate the changes in prevalence, severity profile, and treatment modalities used ... ...

The burden of atopic dermatitis in Portuguese patients: an observational study | Scientific Reports

Nature.com - 02 Mar 2024
The burden of atopic dermatitis in Portuguese patients: an observational study | Scientific Reports ...

Atopic Dermatitis: 5 Things to Know

Medscape - 11 Oct 2023
Atopic Dermatitis: 5 Things to Know ...

Atopic Dermatitis